Cholesterol-lowering drugs may also lower PSA, but whether they cut cancer risk is still not known

November 1st, 2008 by admin

(Duke University Medical Center) Popular cholesterol-busting drugs — statins — materialize to modify men’s protein values along with their cholesterin levels, according to researchers in the Duke Prostate Center and the metropolis Veterans Affairs Medical Center. But whether the drugs preclude endocrine cancer ontogeny or meet cover it is not famous yet.

Tags: , , , ,

Posted in Cancer |

Related posts

Comments are closed.